This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Chimeric antigen receptor
Canadian Cancer Immunotherapy Consortium
Clustered regularly interspaced short palindromic repeats
Cytotoxic T lymphocyte-associated protein-4
Frizzled class receptor 5
Human epidermal growth factor receptor-2
Mitogen-activated protein kinase
Major histocompatibility complex
Natural killer T
Programmed cell death protein-1
Programmed death ligand
RAS-type GTPase family
Repulsive guidance molecule b
Ring finger protein 43
T cell antigen coupler
T cell immunoglobulin and mucin domain 3
Vesicular stomatitis virus
X-box binding protein-1
Conflict of interest
The authors declare no conflicts of interest. Connie Krawczyk participated in the organization of this meeting as coordinator of knowledge dissemination and outreach.
Maartje C. A. Wouters, Jeanette E. Boudreau, and Connie. M. Krawczyk contributed equally.
About this article
Cite this article
Wouters, M.C.A., Laumont, C.M., Chen, B. et al. The Summit for Cancer Immunotherapy (Summit4CI), June 26–29, 2016 Halifax, Canada. Cancer Immunol Immunother 66, 811–818 (2017). https://doi.org/10.1007/s00262-017-1996-9
- Oncolytic virus
- Tumor microenvironment
- Precision medicine
- Cancer genetics